Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care.

Hayes P, Casey M, Glynn LG, Molloy GJ, Durand H, O'Brien E, Dolan E, Newell J, Murphy AW.

Br J Gen Pract. 2018 May 8. pii: bjgp18X696221. doi: 10.3399/bjgp18X696221. [Epub ahead of print]

PMID:
29739776
2.

Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.

Midani FS, Weil AA, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC.

J Infect Dis. 2018 Apr 12. doi: 10.1093/infdis/jiy192. [Epub ahead of print]

PMID:
29659916
3.

Judgement analysis of case severity and future risk of disability regarding chronic low back pain by general practitioners in Ireland.

Dwyer CP, MacNeela P, Durand H, Gibbons A, Reynolds B, Doherty E, Conneely S, Slattery BW, Murphy AW, McGuire BE.

PLoS One. 2018 Mar 26;13(3):e0194387. doi: 10.1371/journal.pone.0194387. eCollection 2018.

4.

Prognosis of patients with apparent treatment-resistant hypertension-a feasibility study.

Hayes P, Kielty H, Casey M, Glynn LG, Molloy GJ, Durand H, Newell J, Murphy AW.

Pilot Feasibility Stud. 2018 Jan 30;4:43. doi: 10.1186/s40814-018-0232-5. eCollection 2018.

5.

Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content.

Arger CA, Heil SH, Sigmon SC, Tidey JW, Stitzer ML, Gaalema DE, Durand HJ, Bunn JY, Ruggieri EK, Higgins ST.

Exp Clin Psychopharmacol. 2017 Dec;25(6):473-478. doi: 10.1037/pha0000145.

PMID:
29251976
6.

Factors Influencing the Application of a Biopsychosocial Perspective in Clinical Judgement of Chronic Pain: Interactive Management with Medical Students.

Dwyer CP, McKenna-Plumley PE, Durand H, Gormley EM, Slattery BW, Harney OM, MacNeela P, McGuire BE.

Pain Physician. 2017 Sep;20(6):E951-E960.

7.

Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction.

Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Hughes JR, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Reed DD, Skelly JM, Tursi L.

JAMA Psychiatry. 2017 Oct 1;74(10):1056-1064. doi: 10.1001/jamapsychiatry.2017.2355.

PMID:
28832876
8.

Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.

Durand H, Hayes P, Morrissey EC, Newell J, Casey M, Murphy AW, Molloy GJ.

J Hypertens. 2017 Dec;35(12):2346-2357. doi: 10.1097/HJH.0000000000001502. Review.

PMID:
28777133
9.

Evidence of positive selection towards Zebuine haplotypes in the BoLA region of Brangus cattle.

Goszczynski DE, Corbi-Botto CM, Durand HM, Rogberg-Muñoz A, Munilla S, Peral-Garcia P, Cantet RJC, Giovambattista G.

Animal. 2018 Feb;12(2):215-223. doi: 10.1017/S1751731117001380. Epub 2017 Jul 14.

PMID:
28707606
10.

Erratum to: Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic review and meta-analysis protocol.

Morrissey EC, Durand H, Nieuwlaat R, Navarro T, Haynes RB, Walsh JC, Molloy GJ.

Syst Rev. 2017 Feb 17;6(1):30. doi: 10.1186/s13643-017-0429-3. No abstract available.

11.

Effectiveness and content analysis of interventions to enhance medication adherence and blood pressure control in hypertension: A systematic review and meta-analysis.

Morrissey EC, Durand H, Nieuwlaat R, Navarro T, Haynes RB, Walsh JC, Molloy GJ.

Psychol Health. 2017 Oct;32(10):1195-1232. doi: 10.1080/08870446.2016.1273356. Epub 2017 Jan 27. Review.

PMID:
28125902
12.

MALDI-TOF mass spectrometry for rapid diagnosis of postoperative endophthalmitis.

Mailhac A, Durand H, Boisset S, Maubon D, Berger F, Maurin M, Chiquet C, Bidart M.

J Proteomics. 2017 Jan 30;152:150-152. doi: 10.1016/j.jprot.2016.10.017. Epub 2016 Oct 29.

PMID:
27989942
13.

State Versus Trait: Validating State Assessment of Child and Parental Catastrophic Thinking About Children's Acute Pain.

Durand H, Birnie KA, Noel M, Vervoort T, Goubert L, Boerner KE, Chambers CT, Caes L.

J Pain. 2017 Apr;18(4):385-395. doi: 10.1016/j.jpain.2016.11.012. Epub 2016 Dec 2.

PMID:
27919776
14.

Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects.

Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, Redner R, Vandrey R, Pacek LR.

Psychopharmacology (Berl). 2017 Jan;234(1):89-98. doi: 10.1007/s00213-016-4438-z. Epub 2016 Oct 6.

15.

Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.

Touat-Hamici Z, Weidmann H, Blum Y, Proust C, Durand H, Iannacci F, Codoni V, Gaignard P, Thérond P, Civelek M, Karabina SA, Lusis AJ, Cambien F, Ninio E.

Cardiovasc Res. 2016 Dec;112(3):702-713. Epub 2016 Sep 30.

16.

Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic review and meta-analysis protocol.

Morrissey EC, Durand H, Nieuwlaat R, Navarro T, Haynes RB, Walsh JC, Molloy GJ.

Syst Rev. 2016 Jun 7;5:96. doi: 10.1186/s13643-016-0278-5. Review. Erratum in: Syst Rev. 2017 Feb 17;6(1):30.

17.

Effectiveness of a biopsychosocial e-learning intervention on the clinical judgements of medical students and GP trainees regarding future risk of disability in patients with chronic lower back pain: study protocol for a randomised controlled trial.

Dwyer CP, Durand H, MacNeela P, Reynolds B, Hamm RM, Main CJ, O'Connor LL, Conneely S, Taheny D, Slattery BW, O'Neill C, NicGabhainn S, Murphy AW, Kropmans T, McGuire BE.

BMJ Open. 2016 May 26;6(5):e010407. doi: 10.1136/bmjopen-2015-010407.

18.

SASH1, a new potential link between smoking and atherosclerosis.

Weidmann H, Touat-Hamici Z, Durand H, Mueller C, Chardonnet S, Pionneau C, Charlotte F, Janssen KP, Verdugo R, Cambien F, Blankenberg S, Tiret L, Zeller T, Ninio E.

Atherosclerosis. 2015 Oct;242(2):571-9. doi: 10.1016/j.atherosclerosis.2015.08.013. Epub 2015 Aug 14.

PMID:
26318107
19.

Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study.

Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, Alili R, Chelghoum N, Pelloux V, Aron-Wisnewsky J, Torcivia A, Bouillot JL, Parks BW, Ninio E, Clément K, Tiret L.

PLoS One. 2015 May 4;10(5):e0125718. doi: 10.1371/journal.pone.0125718. eCollection 2015.

20.

Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.

Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V.

Psychoneuroendocrinology. 2012 Nov;37(11):1885-95. doi: 10.1016/j.psyneuen.2012.03.024. Epub 2012 Apr 26.

PMID:
22541937
21.

Antagonistic regulation of macrophage phenotype by M-CSF and GM-CSF: implication in atherosclerosis.

Brochériou I, Maouche S, Durand H, Braunersreuther V, Le Naour G, Gratchev A, Koskas F, Mach F, Kzhyshkowska J, Ninio E.

Atherosclerosis. 2011 Feb;214(2):316-24. doi: 10.1016/j.atherosclerosis.2010.11.023. Epub 2010 Nov 27.

PMID:
21159337
22.

In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects.

Grimoud J, Durand H, de Souza S, Monsan P, Ouarné F, Theodorou V, Roques C.

Int J Food Microbiol. 2010 Nov 15;144(1):42-50. doi: 10.1016/j.ijfoodmicro.2010.09.007. Epub 2010 Sep 17.

PMID:
20951454
23.

Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study.

Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S.

Ther Adv Respir Dis. 2010 Oct;4(5):271-8. doi: 10.1177/1753465810379010. Epub 2010 Aug 20.

PMID:
20729255
24.

In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics.

Grimoud J, Durand H, Courtin C, Monsan P, Ouarné F, Theodorou V, Roques C.

Anaerobe. 2010 Oct;16(5):493-500. doi: 10.1016/j.anaerobe.2010.07.005. Epub 2010 Jul 27.

PMID:
20670686
25.

A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1.

Morange PE, Bezemer I, Saut N, Bare L, Burgos G, Brocheton J, Durand H, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Germain M, Nicaud V, Heath S, Ninio E, Delluc A, Münzel T, Zeller T, Brand-Herrmann SM, Alessi MC, Tiret L, Lathrop M, Cambien F, Blankenberg S, Emmerich J, Trégouët DA, Rosendaal FR.

Am J Hum Genet. 2010 Apr 9;86(4):592-5. doi: 10.1016/j.ajhg.2010.02.011. Epub 2010 Mar 11. Erratum in: Am J Hum Genet. 2010 Apr 9;86(4):655.

26.

Probiotics in animal nutrition and health.

Chaucheyras-Durand F, Durand H.

Benef Microbes. 2010 Mar;1(1):3-9. doi: 10.3920/BM2008.1002. Review.

PMID:
21840795
27.

Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial.

Diop L, Guillou S, Durand H.

Nutr Res. 2008 Jan;28(1):1-5. doi: 10.1016/j.nutres.2007.10.001.

PMID:
19083380
28.

Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function.

Karabina SA, Brochériou I, Le Naour G, Agrapart M, Durand H, Gelb M, Lambeau G, Ninio E.

FASEB J. 2006 Dec;20(14):2547-9. Epub 2006 Oct 31.

PMID:
17077289
29.

PAF-receptor is preferentially expressed in a distinct synthetic phenotype of smooth muscle cells cloned from human internal thoracic artery: functional implications in cell migration.

Stengel D, O'Neil C, Brochériou I, Karabina SA, Durand H, Caplice NM, Pickering JG, Ninio E.

Biochem Biophys Res Commun. 2006 Aug 4;346(3):693-9. Epub 2006 Jun 12.

PMID:
16793019
30.

Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus.

Wootton PT, Stephens JW, Hurel SJ, Durand H, Cooper J, Ninio E, Humphries SE, Talmud PJ.

Atherosclerosis. 2006 Nov;189(1):149-56. Epub 2006 Jan 24.

PMID:
16438975
31.

Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis.

Pégorier S, Stengel D, Durand H, Croset M, Ninio E.

Atherosclerosis. 2006 Oct;188(2):433-43. Epub 2005 Dec 28.

PMID:
16386258
32.

Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.

Androulakis N, Durand H, Ninio E, Tsoukatos DC.

J Lipid Res. 2005 Sep;46(9):1923-32. Epub 2005 Jul 1.

33.

[Implementation of new plant-health strategies].

Durand H.

C R Biol. 2003 Jan;326(1):47-9. Review. French. No abstract available.

PMID:
12741181
34.

[Churg-Strauss syndrome. Retrospective study of 20 cases].

Haas C, Le Jeunne C, Choubrac P, Durand H, Hugues FC.

Bull Acad Natl Med. 2001;185(6):1113-30; discussion 1130-3. French.

PMID:
11717829
35.

ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase.

Lassot I, Ségéral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T, Benarous R, Margottin-Goguet F.

Mol Cell Biol. 2001 Mar;21(6):2192-202.

36.

[Sarcoidosis-induced pleural thickening: a case report].

Haas C, Gisselbrecht M, Lowenstein W, Durand H.

Ann Med Interne (Paris). 2000 Oct;151(6):516-8. French. No abstract available.

PMID:
11104934
37.

[Pneumopathies caused by inhalation of hydrocarbons: apropos of 3 cases].

Haas C, Lebas FX, Le Jeunne C, Lowenstein W, Durand H, Hugues FC.

Ann Med Interne (Paris). 2000 Oct;151(6):438-47. Review. French.

PMID:
11104922
38.

Relevance of urinalysis monitoring of methadone maintenance patients: a clinical-biological agreement on 41 patients.

Fellous J, Lowenstein W, Gourarier L, Bonan B, Manuel N, Dauphin A, Fermanian J, Durand H.

Addict Biol. 2000 Jul 1;5(3):313-8. doi: 10.1111/j.1369-1600.2000.tb00196.x.

PMID:
20575846
39.

[Severe cytomegalovirus enteritis in AIDS. Favorable outcome of medical treatment].

Haas C, Marteau P, Roudière L, Gisselbrecht M, Lowenstein W, Durand H.

Presse Med. 2000 Mar 25;29(11):596-7. French. No abstract available.

PMID:
10776415
40.

Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP.

Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, Bachelerie F, Arenzana-Seisdedos F, Benarous R.

J Biol Chem. 1999 Mar 19;274(12):7941-5.

41.

The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P.

Curr Biol. 1999 Feb 25;9(4):207-10.

42.

[Case report of an "iron eater"].

Haas C, Choubrac P, Tinel G, Gisselbrecht M, Lowenstein W, Durand H.

Ann Med Interne (Paris). 1998 Nov;149(7):467-8. French. No abstract available.

PMID:
9921403
43.

A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.

Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R.

Mol Cell. 1998 Mar;1(4):565-74.

44.

Dictyostelium discoideum cells shed vesicles with associated DNA and vital stain Hoechst 33342.

Tatischeff I, Bomsel M, de Paillerets C, Durand H, Geny B, Segretain D, Turpin E, Alfsen A.

Cell Mol Life Sci. 1998 May;54(5):476-87.

PMID:
9645228
45.

Inhibition of prokaryotic cell growth by HIV1 Vpr.

Bodéus M, Margottin F, Durand H, Rouer E, Benarous R.

Res Virol. 1997 May-Jun;148(3):207-13.

PMID:
9201811
46.

Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.

Tran PL, Weinbach J, Opolon P, Linares-Cruz G, Reynes JP, Grégoire A, Kremer E, Durand H, Perricaudet M.

J Clin Invest. 1997 Feb 15;99(4):608-17.

47.

[Images suggestive of hepatic metastases: value of MRI with fat saturation].

Gisselbrecht M, Cuenod CA, Bely N, Carnot F, Haas C, Durand H.

Ann Med Interne (Paris). 1997;148(8):563-4. French. No abstract available.

PMID:
9538402
48.

[Withdrawal syndrome in 2 drug addicts after intravenous injection of buprenorphine?].

Gourarier L, Lowenstein W, Gisselbrecht M, Chauveau JM, Haas C, Durand H.

Presse Med. 1996 Sep 21;25(27):1239-40. French.

PMID:
8949735
49.

Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.

Margottin F, Benichou S, Durand H, Richard V, Liu LX, Gomas E, Benarous R.

Virology. 1996 Sep 15;223(2):381-6.

50.

[Rupture of the long biceps tendon following ingestion of fluoroquinolone].

Guérin B, Grateau G, Quartier G, Durand H.

Ann Med Interne (Paris). 1996;147(1):69. French. No abstract available.

PMID:
8763095

Supplemental Content

Loading ...
Support Center